Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn what to look for in no fee cashback card comparisons. Make informed choices to maximize your financial benefits.
15,402 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Oil trades around $78 a barrel on July 13, 2026, keeping gas budgets in focus. Here is the latest on the current pric...
A popular SPIA offers $2,200 monthly from a $350,000 lump sum, yet the contract hides key costs: fixed payments, loss...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
Micron Technology sits around $905 as the AI memory stock rally faces questions. Here are three reasons investors may...
A trio of tech giants is sending a quiet, powerful message about AI infrastructure spending. SpaceX, Alphabet, and SK...
As crude prices rise, Occidental Petroleum trims its 2026 capital spending. This deep dive explains what the move mea...
A widening gap between data-center demand and supply is boosting heavy equipment and power-management stocks. Discove...
Microsoft CEO Satya Nadella charts a pragmatic path for enterprise AI: keep data within your own boundary, govern wit...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
Richtech Robotics faced a sharp pullback in early 2026, driven by execution missteps and market concerns. This piece ...
A high-potential, under-the-radar AI stock could turn the tide against the giants. Snowflake blends data cloud power ...